510(k) · Cleared
ClearedMedient Middle Turbinate Implant; (Single Pack-1 Pair, Four Pack-4 Pair)
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Entrigue Surgical, Inc. · LYA Splint, Intranasal Septal
Cleared on May 29, 2013 as substantially equivalent to K002131 (Walter Lorenz Surgical, Inc., 2001) and 1 other predicate after a 106-day review. Its family tree reaches back 1 generation to 2001. 1 later device descends from it.
- Decided
- May 29, 2013
- Review
- 106 days
- Class
- Class I
- Product code
- LYA
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K002131 (2001). 2 ancestors in all. 1 later device descends from it, 1 citing it directly.
Most influential descendants
Showing 1 of 1 · See all- K243655TurbAlignSpirair, Inc. · 2025 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K002131 | Lactosorb Ethmoid Stent | Walter Lorenz Surgical, Inc. | 2001 | — |
| 0 (this device) | K130354 | Medient Middle Turbinate Implant; (Single Pack-1 Pair, Four Pack-4 Pair) | Entrigue Surgical, Inc. | 2013 | — |
| +1 | K243655 | TurbAlign | Spirair, Inc. | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2004 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LYA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LYA device
- #1 K243655 TurbAlignscore 10.0 · 2 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K002131 | Lactosorb Ethmoid StentSummary page 1…R. § 874.4780) Classification: Class I Predicate Devices: Walter Lorenz Surgical Inc., LactoSorb® Ethmoid Stent [K002131] Medtronic Xomed Inc., MeroPack TM Nasal Packing and Sinus Stent [K04… | 2001 |
| * | K041381 | Meropack Bioresorbable Nasal Packing and Sinus StentSummary page 1…tent [K002131] Medtronic Xomed Inc., MeroPack TM Nasal Packing and Sinus Stent [K041 381] Intended Use/ The MedliENTO Middle Turbinate Implant is intended to Indications for Use: separate the… | 2004 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K243655 | TurbAlign | 2025 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All LYA devicesLYA Splint, Intranasal Septal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.
FDA decisions per year · LYA
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LYA
104in 2014
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LYA
No recall names LYA since 2007.
Adverse event reports per year · LYA
1in 2025
MAUDE reports naming product code LYA, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 2 |
| 2008 | 2 | — | 0 | 0 |
| 2009 | 1 | — | 0 | 5 |
| 2010 | 0 | — | 0 | 2 |
| 2011 | 0 | — | 0 | 16 |
| 2012 | 1 | — | 0 | 16 |
| 2013 | 2 | — | 0 | 1 |
| 2014 | 5 | 104 | 0 | 4 |
| 2015 | 0 | — | 0 | 28 |
| 2016 | 1 | — | 0 | 28 |
| 2017 | 2 | — | 0 | 10 |
| 2018 | 2 | — | 0 | 19 |
| 2019 | 0 | — | 0 | 5 |
| 2020 | 1 | — | 0 | 6 |
| 2021 | 1 | — | 0 | 19 |
| 2022 | 0 | — | 0 | 8 |
| 2023 | 1 | — | 0 | 17 |
| 2024 | 0 | — | 0 | 7 |
| 2025 | 1 | — | 0 | 1 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The MediENT® Middle Turbinate Implant is intended to separate the middle turbinate from the lateral nasal wall during the clinically relevant healing phase associated with nasal/sinus surgery. The implant provides short-term fixation of the middle turbinate to the nasal septum and thus minimizes the risk of adherence to the lateral nasal wall.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K130354 · printed Nov 4, 2026
Cite this page
510(k) Report. “K130354: Medient Middle Turbinate Implant; (Single Pack-1 Pair, Four Pack-4 Pair).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K130354
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026